Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Falling Comet
1911.3000 -21.90 (-1.13%)
NSE Sep 30, 2025 15:31 PM
Volume: 1.0M
 

1911.30
-1.13%
Chola Wealth Direct
in domestic market w ith Net Sales of INR 112.9bn w ith a strong brand portfolio. R&D; cost is in excess of 8% of Sales. Exports account for 73% w ith Developed Markets ( DM) at 58% and EM at 15%. Sales Mix: A PI - 10%, Domestic For mulations - 25%, DM For mulations - 56%, EM For mulations - 9%. Historically strong in anti- TB segment, has built expertise in fer mentation based products and segments like...
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended